Your browser doesn't support javascript.
loading
BTApep-TAT peptide inhibits ADP-ribosylation of BORIS to induce DNA damage in cancer.
Zhang, Yanmei; Fang, Mengdie; Li, Shouye; Xu, Hao; Ren, Juan; Tu, Linglan; Zuo, Bowen; Yao, Wanxin; Liang, Guang.
Afiliação
  • Zhang Y; School of Laboratory Medicine and Bioengineering, Hangzhou Medical College, Hangzhou, 310013, China. yanmeizhang@hmc.edu.cn.
  • Fang M; School of Laboratory Medicine and Bioengineering, Hangzhou Medical College, Hangzhou, 310013, China.
  • Li S; College of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou, 310014, Zhejiang, China.
  • Xu H; School of Laboratory Medicine and Bioengineering, Hangzhou Medical College, Hangzhou, 310013, China.
  • Ren J; Zhejiang Eyoung Pharmaceutical Research and Development Center, Hangzhou, 311258, Zhejiang, China.
  • Tu L; School of Laboratory Medicine and Bioengineering, Hangzhou Medical College, Hangzhou, 310013, China.
  • Zuo B; School of Laboratory Medicine and Bioengineering, Hangzhou Medical College, Hangzhou, 310013, China.
  • Yao W; School of Laboratory Medicine and Bioengineering, Hangzhou Medical College, Hangzhou, 310013, China.
  • Liang G; School of Laboratory Medicine and Bioengineering, Hangzhou Medical College, Hangzhou, 310013, China.
Mol Cancer ; 21(1): 158, 2022 08 02.
Article em En | MEDLINE | ID: mdl-35918747

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Proteínas de Ligação a DNA / Neoplasias Pulmonares Limite: Animals / Humans Idioma: En Revista: Mol Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Proteínas de Ligação a DNA / Neoplasias Pulmonares Limite: Animals / Humans Idioma: En Revista: Mol Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China País de publicação: Reino Unido